933696-63-0 Usage
Description
2-(3-(Methylsulfonyl)phenyl)ethanamine is an organic compound that features a phenyl ring with a methylsulfonyl group attached to the 3rd position and an ethanamine group connected to the 2nd position. 2-(3-(methylsulfonyl)phenyl)ethanamine is characterized by its unique chemical structure and properties, making it a valuable component in various applications.
Uses
Used in Pharmaceutical Research:
2-(3-(Methylsulfonyl)phenyl)ethanamine is used as a key intermediate in the synthesis of piperidinoneand piperidine-constrained phenethylamines. These compounds are being studied and discovered as novel DPP4 inhibitors, which are important in the development of new drugs for the treatment of type 2 diabetes and other related conditions.
In the pharmaceutical industry, 2-(3-(methylsulfonyl)phenyl)ethanamine plays a crucial role in the development of innovative therapeutic agents. Its unique structure allows for the creation of new molecules with potential applications in treating various diseases, particularly those related to metabolic disorders. By serving as a building block in the synthesis of DPP4 inhibitors, this compound contributes to the advancement of medical research and the discovery of more effective treatments.
Check Digit Verification of cas no
The CAS Registry Mumber 933696-63-0 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 9,3,3,6,9 and 6 respectively; the second part has 2 digits, 6 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 933696-63:
(8*9)+(7*3)+(6*3)+(5*6)+(4*9)+(3*6)+(2*6)+(1*3)=210
210 % 10 = 0
So 933696-63-0 is a valid CAS Registry Number.
933696-63-0Relevant articles and documents
Discovery and structure - Activity relationships of piperidinone- and piperidine-constrained phenethylamines as novel, potent, and selective dipeptidyl peptidase IV inhibitors
Pei, Zhonghua,Li, Xiaofeng,Von Geldern, Thomas W.,Longenecker, Kenton,Pireh, Daisy,Stewart, Kent D.,Backes, Bradley J.,Lai, Chunqiu,Lubben, Thomas H.,Ballaron, Stephen J.,Beno, David W. A.,Kempf-Grote, Anita J.,Sham, Hing L.,Trevillyan, James M.
, p. 1983 - 1987 (2008/02/04)
Dipeptidyl peptidase IV (DPP4) inhibitors are emerging as a new class of therapeutic agents for the treatment of type 2 diabetes. They exert their beneficial effects by increasing the levels of active glucagon-like peptide-1 and glucose-dependent insulino
